Castle Biosciences Overview
Castle Biosciences Target Price
See Castle Biosciences's analyst price targets ($39) vs the current share price.
Get informed when a big investor buys or sells
+ FollowShare Price
$34.53
Average Target Price
$38.75
12.2% upside
12.2% upside4 analysts in the last 4 months
High: $44 | Low: $35
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-08-03 | BTIGSung Ji Nam | $44 | 27.4% upside |  |
| 2026-07-31 | Robert W. Baird | $36 | 4.3% upside | |
| 2026-06-24 | Roth Capital | $40 | 15.8% upside | |
| 2026-05-29 | KeyBanc | $35 | 1.4% upside | |
| 2026-04-20 | Canaccord GenuityKyle Mikson | $40 | 15.8% upside | |
| 2026-01-29 | KeyBancPaul Knight | $50 | 44.8% upside | |
| 2026-01-26 | GuggenheimSubbu Nambi | $47 | 36.1% upside | |
| 2026-01-12 | Lake Street | $52 | 50.6% upside | |
| 2026-01-05 | Guggenheim | $43 | 24.5% upside | |
| 2025-12-22 | Canaccord Genuity | $50 | 44.8% upside | |
| 2025-12-12 | BTIGMark Massaro | $50 | 44.8% upside | |
| 2025-03-28 | GuggenheimSubbu Nambi | $30 |  13.1% downside | |
| 2025-02-28 | Robert W. Baird | $37 | 7.2% upside | |
| 2024-11-05 | BTIGSung Ji Nam | $45 | 30.3% upside | |
| 2024-11-05 | Robert W. BairdCatherine Schulte | $39 | 12.9% upside | |
| 2024-11-05 | KeyBancPaul Knight | $36 | 4.3% upside | |
| 2024-10-29 | Canaccord GenuityKyle Mikson | $42 | 21.6% upside | |
| 2024-10-14 | BTIGSung Ji Nam | $40 | 15.8% upside | |
| 2024-08-06 | BTIGSung Ji Nam | $35 | 1.4% upside | |
| 2022-11-04 | Robert W. BairdCatherine Schulte Analyst | $41 | 18.7% upside | |